Skip to main content

Market Overview

Leerink Upgrades Vocera Communications Following Proprietary Survey

Share:

Shares of Vocera Communications Inc (NYSE: VCRA) spiked higher by more than 7 percent Monday after analysts at Leerink upgraded the stock.

David Larsen, Leerink's Health Care Services analyst, upgraded Vocera to Outperform from Market Perform with an unchanged $14 price target following a proprietary survey which indicated "solid demand" for its products and services.

Larsen noted that he commissioned MEDACorp to oversee a survey of 37 hospital administrators to study trends in the Wireless Communication market. The study concluded that satisfaction scores amongst Vocera's clients were "high." In addition, the study concluded that a "large portion" of Vocera users expect to purchase additional badges over the next year as overall spending on communication and care coordination solutions is expected to rise through 2017.

"We believe that nurses value the hands-free nature of the badge," Larsen also concluded from the study. "We also believe that Vocera's investments into secure texting, patient engagement, communication, and integration into EMRs, are all making the full portfolio of products attractive to hospitals. Integrated Delivery Networks (IDNs) can use Vocera to improve HCAHP scores, which is becoming increasingly important as ACOs and patients begin to shop more aggressively for care."

Larsen continued that the study showed four "positive drivers" that are not fully appreciated by the investment community. The drivers include: 1) improving industry fundamentals where hospitals are purchasing more care coordination, 2) Vocera has beat the high-end of its revenue guidance in each of the past four quarters, 3) Vocera is shifting itself to a "care coordination platform," and 4) Vocera could eventually be acquired given its "high" product quality with a large client base.

Latest Ratings for VCRA

DateFirmActionFromTo
Jan 2022BairdDowngradesOutperformNeutral
Jan 2022SVB LeerinkUpgradesUnderperformMarket Perform
Jan 2022Piper SandlerDowngradesOverweightNeutral

View More Analyst Ratings for VCRA

View the Latest Analyst Ratings

 

Related Articles (VCRA)

View Comments and Join the Discussion!

Posted-In: David Larsen HCAHP healthcare Leerink MEDACorpAnalyst Color Upgrades Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com